Background: The development of effective cosmetic products for the reduction of the signs of skin aging is a complex process which requires an optimized combination of ingredients and specialized systems to deliver the actives to the skin layers.Aim: To evaluate the tolerance and antiaging clinical efficacy of a cosmetic formulation containing a blend of nanoencapsulated antioxidants: ascorbyl palmitate, resveratrol, tocopherol, caffeine, carnosine, and niacinamide.Methods: Clinical efficacy was determined by subjective and instrumental analyses of collagen synthesis by fluorescence spectroscopy, by three‐dimensional imaging analysis of suborbital edema, and by analysis of skin hydration and sebum content by biophysical techniques—Corneometer® and Sebumeter®.Results: The studied formulation was safe and effective for the improvement of skin appearance by increasing collagen synthesis and skin moisturizing and by reducing facial blemishes, swelling, and oiliness. A preclinical exploratory approach using an experimental model of human cell and skin cultures agreed with the observed antiaging effects, identifying mechanisms related to the containment of oxidative stress, reduction of melanin production, increased synthesis of type I procollagen, and regulation of the epidermal cohesion protein filaggrin.Conclusions: The skin benefits obtained resulted from the combination of the ingredients in the formulation and the nanoencapsulation‐based delivery system, which favors the solubility, safety, efficacy, and bioavailability of the preparation to the skin.
Background: The development of sunscreens with properties beyond photoprotection involves carefully optimizing the blend of ingredients and employing advanced systems to ensure effective delivery through the skin layers.Aims: The aim of this study was to evaluate the efficacy of a multifunctional photoprotective formulation containing a blend of nanoencapsulated ingredients—ascorbyl palmitate, caffeine, and resveratrol—and the active ingredients niacinamide, hyaluronic acid, bisabolol, tocopherol, and carnosine in skin protection against UV and blue light radiations, by in vitro, ex vivo, and clinical studies.Methods: A preclinical approach using human explants was performed to evaluate the protective effects of a sunscreen formulation against damage induced by UV and blue light radiation. In addition, a clinical trial was carried out to evaluate skin acceptability, protection from UV‐A and UV‐B, collagen synthesis by fluorescence spectroscopy, and skin hydration.Results: The results of the preclinical study showed that the proposed formulation prevented UV‐induced reactive oxygen species (ROS) production and stimulated the levels of epidermal opsin‐3 photoreceptors, ensuring melanogenesis control. The clinical study showed that the sunscreen was well‐tolerated by both skin and eyes, improved skin conditions by upregulating collagen synthesis, and moisturizing the skin.Conclusion: The combination of the active ingredients in the proposed formulation was safe and effective for skin protection against ultraviolet radiation, besides promoting collagen synthesis and opsin‐3 stimulus.